Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): Association between a promoter polymorphism and type 1 diabetes in Asian populations

American Journal of Medical Genetics

Volumn 140 A, Issue 6, 2006, Pages 586-593

  Kawasaki, Eiji ^a   Awata, Takuya ^b   Ikegami, Hiroshi ^c   Kobayashi, Tetsuro ^d   Maruyama, Taro ^e   Nakanishi, Koji ^f   Shimada, Akira ^g   Uga, Mho ^a   Kurihara, Susumu ^b   Kawabata, Yumiko ^c   Tanaka, Shoichiro ^d   Kanazawa, Yasuhiko ^g   Lee, Inkyu ^h   Eguchi, Katzumi ⁱ  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

^e SAITAMA SOCIAL INSURANCE HOSPITAL   (Japan)

^f TORANOMON HOSPITAL   (Japan)

^g KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h Kyungpook National University Hospital   (South Korea)

ⁱ NAGASAKI UNIVERSITY   (Japan)

Author keywords

Association study; Autoimmunity; Polymorphism; Promoter; PTPN22; Transmission disequilibrium test; Type 1 diabetes

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; CAUCASIAN; CHILD; CHROMOSOME 1P; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; EUROPE; FAMILY HISTORY; FEMALE; GENE; GENE AMPLIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ASSOCIATION; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; KOREA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PTPN22 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; T LYMPHOCYTE ACTIVATION;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; KOREA; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE-PHOSPHATASE;

EID: 33644851944     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31124     Document Type: Article

References (32)

1. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SY, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffery DA, Lee AT, Batliwalla F, Remmers E, Criswell LA, Seldin MF, Kastner DL, Amos CI, Sninsky JJ, Gregersen PK. 2004. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75:330-337.
2. Bell GI, Horita S, Karam JH. 1984. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 33:176-183.
3. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T. 2004. A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes. Nat Genet 36:337-338.
4. Comings DE, MacMurray JP. 2000. Molecular heterosis: A review. Mol Genet Metab 71:19-31.
5. Comings DE, MacMurray JP, Gonzalez N, Ferry L, Peters WR. 1999. Association of the serotonin transporter gene with serum cholesterol levels and heart disease. Mol Genet Metab 67:248-253.
6. Comings DE, Gonzalez NS, Cheng Li SC, MacMurray J. 2003. A "line item" approach to the identification of genes involved in polygenic behavioral disorders: The adrenergic a2A (ADRA2A) gene. Am J Med Genet Part B Neuropsychiatr Genet 118B:110-114.
7. Denic S, Khatib F, Awad M, Karbani G, Milenkovic J. 2005. Cancer by negative heterosis: Breast and ovarian cancer excess in hybrids of inbred ethnic groups. Med Hypotheses 64:1002-1006.
8. DerSimonian R, Laird N. 1986. Meta-analysis in clinical trials. Control Clin Trials 7:177-188.
9. Hasegawa K, Martin F, Huang G, Tumas D, Diehl L, Chan AC. 2004. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 303:685-689.
10. Hill RJ, Zozulya S, Lu YL, Ward K, Gishizky M, Jallal B. 2002. The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation. Exp Hematol 30:237-244.
11. Juliger S, Bongartz M, Luty AJ, Kremsner PG, Kun JF. 2003. Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I. Immunogenetics 54:675-680.
12. Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, Carlton VE, Chang M, Ramos P, Baechler EC, Batliwalla FM, Novitzke J, Williams AH, Gillett C, Rodine P, Graham RR, Ardlie KG, Gaffney PM, Moser KL, Petri M, Begovich AB, Gregersen PK, Behrens TW. 2004. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75:504-507.
13. Ladner MB, Bottini N, Valdes AM, Noble JA. 2005. Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. Hum Immunol 66:60-64.
14. Lee HS, Kim SH, Lee HJ, Kim L, Lee SK, Jang DW, Lee MS, Son BG, Suh KY, Kim S. 2002. Gender-specific molecular heterosis of dopamine D2 receptor gene (DRD2) for smoking in schizophrenia. Am J Med Genet Part B Neuropsychiatr Genet 114B:593-597.
15. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, DelProposto ZS, Hill E, Cassin BJ, Watson SJ, Cook EH. 1998. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 155:207-213.
16. Mantel N, Haenszel W. 1959. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
17. Matsuura N, Fukuda K, Okuno A, Harada S, Fukushima N, Koike A, Ito Y, Hotsubo T. 1998. Descriptive epidemiology of IDDM in Hokkaido, Japan: The Childhood IDDM Hokkaido Registry. Diabetes Care 21:1632-1636.
18. Matthews RJ, Bowne DB, Flores E, Thomas ML. 1992. Characterization of hematopoietic intracellular protein tyrosine phosphatases: Description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol 12:2396-2405.
19. Mustelin T, Rahmouni S, Bottini N, Alonso A. 2003. Role of protein tyrosine phosphatases in T cell activation. Immunol Rev 191:139-147.
20. National Diabetes Data Group. 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057.
21. Polanczyk M, Yellayi S, Zamora A, Subramanian S, Tovey M, Vandenbark AA, Offner H, Zachary JF, Fillmore PD, Blankenhorn EP, Gustafsson JA, Teuscher C. 2004. Estrogen receptor-1 (Esr1) and -2 (Esr2) regulate the severity of clinical experimental allergic encephalomyelitis in male mice. Am J Pathol 164:1915-1924.
22. Pooley EC, Fairburn CG, Cooper Z, Sodhi MS, Cowen PJ, Harrison PJ. 2004. A 5-HT2C receptor promoter polymorphism (HTR2C-759C/T) is associated with obesity in women, and with resistance to weight loss in heterozygotes. Am J Med Genet Part B Neuropsychiatr Genet 126B:124-127.
23. Qu H, Tessier MC, Hudson TJ, Polychronakos C. 2005. Confirmation of the association of the R620W polymorphism in the protein tyrosine phosphatase PTPN22 with type 1 diabetes in a family based study. J Med Genet 42:266-270.
24. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Rance HE, Maier L, Barratt BJ, Guja C, Ionescu-Tirgoviste C, Savage DA, Dunger DB, Widmer B, Strachan DP, Ring SM, Walker N, Clayton DG, Twells RC, Gough SC, Todd JA. 2004. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53:3020-3023.
25. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516.
26. Terwillinger J, Otto J. 1994. Handbook of human lingage analysis. Baltimore, MD: Johns Hopkins University Press.
27. Thomson G. 1995. Mapping disease genes: Family-based association studies. Am J Hum Genet 57:487-498.
28. Todd JA, Bell JI, McDevitt HO. 1987. HLA-DQB gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599-604.
29. Tuomilehto J, Virtala E, Karvonen M, Lounamaa R, Pitkaniemi J, Reunanen A, Tuomilehto-Wolf E, Toivanen L, group tDs. 1995. Increase in incedence of insulin-dependent diabetes mellitus among children in Finland. Int J Epidemiol 24:984-992.
30. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506-511.
31. Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, Donaldson PT, Ball SG, James RA, Quinton R, Perros P, Pearce SH. 2004. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 89:5862-5865.
32. Zheng W, She JX. 2005. Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes. Diabetes 54:906-908.